What's new

Human medicines European public assessment report (EPAR): Jemperli, dostarlimab, Date of authorisation: 21/04/2021, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Jemperli, dostarlimab, Date of authorisation: 21/04/2021, Revision: 12, Status: Authorised

Jun 24, 2025 - 15:10
 0
Human medicines European public assessment report (EPAR): Jemperli, dostarlimab, Date of authorisation: 21/04/2021, Revision: 12, Status: Authorised
Human medicines European public assessment report (EPAR): Jemperli, dostarlimab, Date of authorisation: 21/04/2021, Revision: 12, Status: Authorised
Read More

Tags:

Previous Article

EMEA-000834-PIP01-10-M01

Next Article

Opinion/decision on a Paediatric investigation plan (PIP): Entyvio, vedolizumab,...

Related Posts

Opinion/decision on a Paediatric investigation plan (PIP): Comirnaty, Tozinameran,Tozinameran / famtozinameran,tozinameran/ riltozinameran,raxtozinameran, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infections and infestations, PIP number: P/0105/2024

Opinion/decision on a Paediatric investigation plan (PI...

Jun 6, 2025  0

EMEA-003600-PIP01-24

EMEA-003600-PIP01-24

Jun 20, 2025  0

Human medicines European public assessment report (EPAR): Tobi Podhaler, tobramycin, Date of authorisation: 20/07/2011, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR...

May 13, 2025  0